Table 1.
Baseline characteristics of the study participants, according to nonalcoholic fatty liver disease status
| Variables | Without NAFLD | With NAFLD | P value |
| n | 475 | 742 | |
| Sex (female/male) | 287/188 | 470/272 | > 0.05 |
| Age (yr) | 65.11 ± 11.70 | 62.29 ± 12.52 | < 0.05 |
| Diabetes duration (yr) | 11.31 ± 7.10 | 8.47 ± 6.87 | < 0.05 |
| Height (cm) | 163.99 ± 8.49 | 164.20 ± 8.24 | > 0.05 |
| BW (kg) | 65.54 ± 9.76 | 74.32 ± 11.64 | < 0.05 |
| WC (cm) | 88.75 ± 8.72 | 96.76 ± 10.32 | < 0.05 |
| BMI (kg/m2) | 24.33 ± 2.87 | 27.49 ± 3.37 | < 0.05 |
| Current smokers (%) | 17.7 | 14.3 | > 0.05 |
| SBP (mmHg) | 131.43 ± 17.93 | 141.56 ± 16.15 | < 0.05 |
| DBP (mmHg) | 76.94 ± 8.87 | 83.61 ± 9.57 | < 0.05 |
| FBG (mmol/L) | 7.72 ± 3.18 | 8.97 ± 3.20 | < 0.05 |
| HbA1c (%) | 8.45 ± 2.44 | 8.91 ± 2.47 | < 0.05 |
| ALT (mmol/L) | 17.16 ± 8.19 | 25.72 ± 13.01 | < 0.05 |
| AST (mmol/L) | 18.23 ± 6.74 | 22.34 ± 9.00 | < 0.05 |
| GGT (mmol/L) | 19.47 ± 16.32 | 25.05 ± 17.94 | < 0.05 |
| TG (mmol/L) | 1.45 ± 1.06 | 2.12 ± 1.43 | < 0.05 |
| TC (mmol/L) | 4.99 ± 1.41 | 5.04 ± 1.22 | > 0.05 |
| LDL (mmol/L) | 2.95 ± 0.92 | 2.95 ± 0.82 | > 0.05 |
| HDL (mmol/L) | 1.24 ± 0.29 | 1.17 ± 0.28 | < 0.05 |
Data are expressed as mean ± SD or proportions of the entire cohort of participants. BW: Body weight; WC: Waist circumference; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; FBG: Fasting blood glucose; HbA1c: Hemoglobin A1c; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: γ-glutamyltransferase; TG: Triglyceride; TC: Total cholesterol; LDL: Low-density lipoprotein; HDL: High-density lipoprotein.